Clinical Trial Update: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [NA]

View source ↗

Summary

Clinical trial update for sorafenib in locally advanced or metastatic kidney cancer has terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Clear Cell Renal Cell Carcinoma
• Kidney Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Northwestern University | Conditions: Hereditary Clear Cell Renal Cell Carcinoma, Kidney Cancer | NA | Status: TERMINATED | Results posted: 2019-05-03